Influenza News and Research

Latest Influenza News and Research

Flu virus suppresses body's ability to defend against bacteria

When infected with influenza, the body becomes an easy target for bacteria. The flu virus alters the host's immune system and compromises its capacity to effectively fight off bacterial infections. Now, a team of immunologists at the Helmholtz Centre for Infection Research (HZI) and cooperation partners has discovered that an immune system molecule called TLR7 is partly to blame. The molecule recognizes the viral genome - and then signals scavenger cells of the immune system to ingest fewer bacteria.

15 Nov 2012

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner today announced results from a Phase 1 clinical trial of PaxVax's single-dose oral cholera vaccine candidate at the 2012 American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting in Atlanta.

15 Nov 2012

Calcium-related hormone could help identify pneumonia

Serum procalcitonin measurements could improve the accuracy of pneumonia diagnoses when chest radiographs give indeterminate results, indicate US study findings.

12 Nov 2012

Pevion launches Defensomes platform for broad spectrum immune enhancement

Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.

8 Nov 2012

BioCryst completes planned interim analysis of peramivir Phase 3 trial for serious influenza

BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.

8 Nov 2012

Gene silencing technology used to fight RSV and influenza

New hope has arrived for the fight against two deadly viral infections, RSV and influenza, as Griffith researchers prepare to develop a cutting-edge approach to treatment delivery.

6 Nov 2012

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights.

6 Nov 2012

CDC report outlines international influenza activities

The Centers for Disease Control and Prevention (CDC) on Monday released a 268-page annual report that "profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana," CIDRAP News reports.

1 Nov 2012

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.

1 Nov 2012

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst Pharmaceuticals, Inc. announced the withdrawal of its Investigational New Drug application (IND) for the antiviral nucleoside, BCX5191, following a discussion with the U.S. Food and Drug Administration (FDA).

31 Oct 2012

All health care workers should be vaccinated with annual flu vaccine to protect patients

All health care workers in health care institutions should be vaccinated with the annual influenza vaccine to protect patients, argues an editorial in CMAJ (Canadian Medical Association Journal).

30 Oct 2012

Flu shot might also prevent heart disease

Getting a flu shot may not only protect you from getting sick, it might also prevent heart disease.

29 Oct 2012

Guidelines to help protect vulnerable populations from flu

While it is important to get vaccinated against the flu virus as early as possible, it is never too late to reap the benefits of this vaccine. According to The Centers for Disease Control and Prevention, the peak months for the spread of the flu virus are January and February and the season can last into mid-May.

26 Oct 2012

Winter safety tips for older adults

Winter is a special time for celebration. It should also be a time for added caution if you or someone in your family is an older adult. It is the season for falls, slips on icy streets and other dangers that can be especially harmful for older adults.

25 Oct 2012

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

Scientists at Royal Holloway, University of London have developed a pioneering new method of oral vaccination which could help boost immunity to TB and influenza, as well as prevent C. difficile for which there is currently no vaccine.

25 Oct 2012

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

In 2009, a new strain of influenza, or flu, virus emerged and spread rapidly to many countries around the world. It was declared a pandemic by the World Health Organization (WHO) in June 2009.

24 Oct 2012

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi Pasteur, the vaccines division of Sanofi, presented today an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine (QIV).

23 Oct 2012

Researchers discover Hyalomma ticks in migratory birds

A type of haemorrhagic fever (Crimean-Congo) that is prevalent in Africa, Asia, and the Balkans has begun to spread to new areas in southern Europe. Now Swedish researchers have shown that migratory birds carrying ticks are the possible source of contagion.

22 Oct 2012

Chinese herbs may show significant benefits for patients with NSCLC, IPF and influenza

Chinese herbs, including JHQG, BFXL, and BFHX, may show significant benefits for patients with non-small cell lung cancer (NSCLC), idiopathic pulmonary fibrosis (IPF), and influenza.

22 Oct 2012

New data shows influenza-associated deaths among children, effectiveness of school vaccinations

New data being presented at IDWeek 2012TM shows the fatal risk that influenza poses even for children without underlying health conditions and the effectiveness of school-based vaccination programs in protecting student populations.

20 Oct 2012

Influenza News and Research

Latest Influenza News and Research

Flu virus suppresses body's ability to defend against bacteria

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

Calcium-related hormone could help identify pneumonia

Pevion launches Defensomes platform for broad spectrum immune enhancement

BioCryst completes planned interim analysis of peramivir Phase 3 trial for serious influenza

Gene silencing technology used to fight RSV and influenza

Alnylam third quarter 2012 revenues decrease to $16.8 million

CDC report outlines international influenza activities

Novartis resumes distribution of two seasonal influenza vaccines in Canada

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

All health care workers should be vaccinated with annual flu vaccine to protect patients

Flu shot might also prevent heart disease

Guidelines to help protect vulnerable populations from flu

Winter safety tips for older adults

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Researchers discover Hyalomma ticks in migratory birds

Chinese herbs may show significant benefits for patients with NSCLC, IPF and influenza

New data shows influenza-associated deaths among children, effectiveness of school vaccinations

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Influenza News and Research

Latest Influenza News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in